Cargando…
Identification and Analysis of Small Molecule Inhibitors of CRISPR-Cas9 in Human Cells
Genome editing tools based on CRISPR–Cas systems can repair genetic mutations in situ; however, off-target effects and DNA damage lesions that result from genome editing remain major roadblocks to its full clinical implementation. Protein and chemical inhibitors of CRISPR–Cas systems may reduce off-...
Autores principales: | Yang, Yue, Li, Donghua, Wan, Fen, Chen, Bohong, Wu, Guanglan, Li, Feng, Ren, Yanliang, Liang, Puping, Wan, Jian, Songyang, Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688475/ https://www.ncbi.nlm.nih.gov/pubmed/36429003 http://dx.doi.org/10.3390/cells11223574 |
Ejemplares similares
-
CRISPR/Cas9 Promotes Functional Study of Testis Specific X-Linked Gene In Vivo
por: Li, Minyan, et al.
Publicado: (2015) -
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
por: Liang, Puping, et al.
Publicado: (2015) -
Single AAV-Mediated CRISPR-SaCas9 Inhibits HSV-1 Replication by Editing ICP4 in Trigeminal Ganglion Neurons
por: Chen, Yuxi, et al.
Publicado: (2020) -
Live cell imaging and proteomic profiling of endogenous NEAT1 lncRNA by CRISPR/Cas9-mediated knock-in
por: Chen, Bohong, et al.
Publicado: (2020) -
Repurposing type I–F CRISPR–Cas system as a transcriptional activation tool in human cells
por: Chen, Yuxi, et al.
Publicado: (2020)